0AD1 Stock Overview

A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. More details

0AD1 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	1/6
Financial Health	1/6
Dividends	0/6

Rewards

Trading at 35.9% below our estimate of its fair value

Earnings are forecast to grow 18.43% per year

Risk Analysis

Interest payments are not well covered by earnings

Shares are highly illiquid

Profit margins (5.8%) are lower than last year (16.4%)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Solventum Corporation Competitors

ConvaTec Group

LSE:CTEC

UK£5.4b

Advanced Medical Solutions Group

AIM:AMS

UK£438.8m

Smith & Nephew

LSE:SN.

UK£9.5b

Tristel

AIM:TSTL

UK£174.1m

Price History & Performance

Summary of share price highs, lows and changes for Solventum
Historical stock prices
Current Share Price	US$66.25
52 Week High	US$84.34
52 Week Low	US$64.91
Beta	0
1 Month Change	-11.54%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-10.13%

Recent updates

Shareholder Returns

	0AD1	GB Medical Equipment	GB Market
7D	2.1%	6.4%	2.2%
1Y	n/a	3.2%	2.2%

Return vs Industry: Insufficient data to determine how 0AD1 performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how 0AD1 performed against the UK Market.

Price Volatility

Is 0AD1's price volatile compared to industry and market?
0AD1 volatility
0AD1 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.7%
Market Average Movement	5.6%
10% most volatile stocks in GB Market	10.8%
10% least volatile stocks in GB Market	3.1%

Stable Share Price: 0AD1's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine 0AD1's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2023	22,000	Bryan Hanson	www.solventum.com

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.

Solventum Corporation Fundamentals Summary

How do Solventum's earnings and revenue compare to its market cap?
0AD1 fundamental statistics
Market cap	US$11.70b
Earnings (TTM)	US$479.00m
Revenue (TTM)	US$8.25b

24.4x

P/E Ratio

1.4x

P/S Ratio

Is 0AD1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0AD1 income statement (TTM)
Revenue	US$8.25b
Cost of Revenue	US$3.64b
Gross Profit	US$4.61b
Other Expenses	US$4.13b
Earnings	US$479.00m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 08, 2025

Earnings per share (EPS)	2.77
Gross Margin	55.88%
Net Profit Margin	5.80%
Debt/Equity Ratio	270.7%

How did 0AD1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/03 09:52
End of Day Share Price	2025/05/01 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Solventum Corporation is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Travis Steed	BofA Global Research
Travis Steed	BofA Global Research
Michael Gorman	BTIG